# Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

> **NCT07285993** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Randy Yeh** · enrollment: 15 (estimated)

## Conditions studied

- Breast Cancer
- Metastatic Invasive Lobular Breast Cancer

## Interventions

- **DRUG:** 18F-FAPI-74
- **DRUG:** 18F-FDG
- **PROCEDURE:** PET/CT

## Key facts

- **NCT ID:** NCT07285993
- **Lead sponsor:** Randy Yeh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07285993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07285993, "Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07285993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*